You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 2.8% | 3.0% |
| Div Cover | 1.7 | 2.4 |
| Op Mrgn | 24.5% | 37.1% |
| ROCE | 61.2% |
| Latest | Forecast | |
|---|---|---|
| P/E | 21.3 | 1,336.6 |
| PEG | 0.3 | 0.3 |
| Price / Revenue | 4.4 | 4.3 |
| Price / Book value | 8.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 10.7% | -2.6% |
| PBT | 31.8% | n/a |
| EPS | 64.1% | 5.8% |
| DPS | 13.6% | 2.6% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 39,498.00 | 5,401.00 | $1.58 | 33.4 | -0.5 | -62% | $1.81 | 3.4% |
| 2016-12-31 | 39,807.00 | 4,659.00 | €1.42 | 39.4 | -14.6 | -3% | €1.85 | 3.3% |
| 2017-12-31 | 40,122.00 | 6,521.00 | $0.88 | 63.9 | -1.5 | -43% | $1.89 | 3.4% |
| 2018-12-31 | 42,294.00 | 8,701.00 | $2.34 | 32.2 | 0.2 | 166% | $1.99 | 2.6% |
| 2019-12-31 | 46,840.00 | 11,464.00 | $3.84 | 23.7 | 0.4 | 64% | $2.26 | 2.5% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 48,156.55 | 17,849.34 | $5.96 | 1,336.6 | 24.2 | 55% | $2.45 | 306.3% |
| 2021-12-31 | 51,537.15 | 19,106.19 | $6.27 | 1,259.6 | 239.4 | 5% | $2.60 | 325.5% |
| Merck to buy Oncolmmune for $425m Sharecast News | 23 Nov |
|---|---|
| Merck to pursue Covid-19 vaccine using same approach as against Ebola Sharecast News | 26 May |
| Trump set to declare national emergency in US, freeing up funding Sharecast News | 13 Mar |